Task: Answer the multiple choice question.
Question: Which drug exhibits a 13.656% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCN(Cc1ccncc1)C(=O)c1cc(COc2ccc(F)cc2Cl)on1
b. CCCS(=O)(=O)N1CCCC(C(=O)NCCN2CCOCC2)C1
c. COc1ccccc1NS(=O)(=O)c1ccc(O)c(NC(=S)NCC2CCCO2)c1
Answer: b. CCCS(=O)(=O)N1CCCC(C(=O)NCCN2CCOCC2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCS(=O)(=O)N1CCCC(C(=O)NCCN2CCOCC2)C1
CCCS(=O)(=O)N1CCCC(C(=O)NCCN2CCOCC2)C1
N-(2-morpholin-4-ylethyl)-1-propylsulfonylpiperidine-3-carboxamide